Skip to main content

Table 1 illustrates the frequency of major clinical manifestations

From: Activated phosphoinositde 3-kinase (PI3Kδ) syndrome: an Italian point of view on diagnosis and new advances in treatment

Clinical manifestations

 

Infections

V V V

Benign lymphoproliferation

V V V

Autoimmunity

V V

Malignancy

V V

Short stature

(APDS 2)

V

(VV)

Neurodevelopmental delay

(APDS 2)

V

(VV)

  1. • VVV: more than 70% of cases.
  2. • VV: Between 50% and 70% of cases.
  3. • V: less than 50% of cases.